ATE287393T1 - Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung - Google Patents
Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendungInfo
- Publication number
- ATE287393T1 ATE287393T1 AT99907879T AT99907879T ATE287393T1 AT E287393 T1 ATE287393 T1 AT E287393T1 AT 99907879 T AT99907879 T AT 99907879T AT 99907879 T AT99907879 T AT 99907879T AT E287393 T1 ATE287393 T1 AT E287393T1
- Authority
- AT
- Austria
- Prior art keywords
- substituents
- hydrocarbon group
- group optionally
- aliphatic hydrocarbon
- hydrogen atom
- Prior art date
Links
- 150000001925 cycloalkenes Chemical class 0.000 title 1
- 125000001424 substituent group Chemical group 0.000 abstract 7
- 125000001931 aliphatic group Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000020446 Cardiac disease Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000035939 shock Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/14—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Steroid Compounds (AREA)
- Silicon Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5649298 | 1998-03-09 | ||
| JP28436298 | 1998-10-06 | ||
| PCT/JP1999/001103 WO1999046242A1 (en) | 1998-03-09 | 1999-03-08 | Cycloalkene derivatives, process for producing the same, and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE287393T1 true ATE287393T1 (de) | 2005-02-15 |
Family
ID=26397446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99907879T ATE287393T1 (de) | 1998-03-09 | 1999-03-08 | Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6495604B1 (de) |
| EP (2) | EP1063228B1 (de) |
| JP (2) | JP3665712B2 (de) |
| KR (4) | KR20050071719A (de) |
| CN (1) | CN100432049C (de) |
| AT (1) | ATE287393T1 (de) |
| AU (1) | AU747521B2 (de) |
| BR (1) | BR9908610A (de) |
| CA (1) | CA2320467C (de) |
| DE (1) | DE69923300T2 (de) |
| DK (1) | DK1063228T5 (de) |
| ES (1) | ES2232114T3 (de) |
| HU (1) | HU230061B1 (de) |
| ID (1) | ID25649A (de) |
| NO (1) | NO326426B1 (de) |
| NZ (1) | NZ505874A (de) |
| PT (1) | PT1063228E (de) |
| RU (1) | RU2214398C2 (de) |
| WO (1) | WO1999046242A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69923300T2 (de) | 1998-03-09 | 2006-01-05 | Takeda Pharmaceutical Co. Ltd. | Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung |
| US20040220103A1 (en) * | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
| KR100778256B1 (ko) * | 1999-08-06 | 2007-11-27 | 다케다 야쿠힌 고교 가부시키가이샤 | 치환 방향환 화합물, 그의 제조법 및 용도 |
| AU1553001A (en) * | 1999-11-29 | 2001-06-12 | Takeda Chemical Industries Ltd. | Process for the production of optically active cyclohexene derivatives and intermediates therefor |
| CA2400804C (en) | 2000-02-04 | 2009-09-01 | Takeda Chemical Industries, Ltd. | Stable emulsion compositions of cycloalkene derivatives |
| JP4863553B2 (ja) * | 2000-02-04 | 2012-01-25 | 武田薬品工業株式会社 | 安定な乳化組成物 |
| AU2001278705A1 (en) * | 2000-08-10 | 2002-02-25 | Takeda Chemical Industries Ltd. | Pharmaceutical composition |
| JP4922507B2 (ja) * | 2000-08-10 | 2012-04-25 | 武田薬品工業株式会社 | 医薬組成物 |
| CA2426277C (en) | 2000-10-18 | 2010-11-30 | Takeda Chemical Industries, Ltd. | Process for preparation of optically active sulfonamides and intermediates for their synthesis |
| CA2431206C (en) * | 2000-12-08 | 2009-09-01 | Takeda Chemical Industries, Ltd. | Combination drugs containing anti-sepsis cycloalkene compound |
| US7579325B2 (en) | 2001-03-21 | 2009-08-25 | Eisai R & D Management Co., Ltd. | Drugs containing reduced of vitamin B2 |
| EP1420783A4 (de) * | 2001-08-03 | 2009-09-30 | Takeda Pharmaceutical | Stabile emulsionszusammensetzung |
| KR20040099418A (ko) * | 2002-04-08 | 2004-11-26 | 다케다 야쿠힌 고교 가부시키가이샤 | 중증 패혈증 예방 치료제 |
| CA2547410C (en) | 2003-12-03 | 2013-07-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1,2,3-triazole amide derivatives as inhibitors of cytokie production |
| TWI462745B (zh) * | 2005-04-28 | 2014-12-01 | Takeda Pharmaceutical | 安定的乳化組成物 |
| EP1935879B1 (de) * | 2005-09-14 | 2016-05-11 | Daiichi Sankyo Company, Limited | Substituiertes cycloalkenderivat |
| WO2007114296A1 (ja) | 2006-03-30 | 2007-10-11 | Hiroshima University | スクリーニング方法 |
| US20090062355A1 (en) * | 2006-04-20 | 2009-03-05 | Takeda Pharmaceutical Company Limited | Pharmaceutical Product |
| JPWO2007132825A1 (ja) | 2006-05-15 | 2009-09-24 | 武田薬品工業株式会社 | 医薬 |
| EP2039681A4 (de) * | 2006-07-07 | 2009-10-28 | Takeda Pharmaceutical | Cycloalkenderivate, verfahren zur herstellung der derivate und deren verwendung |
| JP2008260760A (ja) * | 2007-03-12 | 2008-10-30 | Daiichi Sankyo Co Ltd | 置換シクロアルケン誘導体を含有する医薬組成物 |
| GEP20166441B (en) | 2010-01-27 | 2016-03-10 | Takeda Pharmaceutical | Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent |
| JP5778161B2 (ja) | 2010-09-24 | 2015-09-16 | 第一三共株式会社 | 置換シクロアルケン誘導体の結晶 |
| US20150174160A1 (en) * | 2012-07-03 | 2015-06-25 | Jay Pravda | Methods for treating, diagnosing and/or monitoring progression of oxo associated states |
| WO2014050910A1 (ja) | 2012-09-26 | 2014-04-03 | 武田薬品工業株式会社 | 固体粒子の製造方法 |
| EA033083B1 (ru) | 2015-05-08 | 2019-08-30 | Такеда Фармасьютикал Компани Лимитед | Циклические соединения |
| WO2018047888A1 (ja) | 2016-09-09 | 2018-03-15 | 武田薬品工業株式会社 | 環状化合物 |
| CN110352189A (zh) * | 2017-02-24 | 2019-10-18 | 景凯生物科技股份有限公司 | 用于预防及/或治疗自体免疫、发炎或感染相关障碍的磺酰胺或酰胺化合物、组合物与方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992007552A1 (fr) | 1990-11-06 | 1992-05-14 | Nippon Shinyaku Co., Ltd. | Preparation lyophilisee et sa production |
| AU653279B2 (en) * | 1991-12-30 | 1994-09-22 | Sanofi | Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| US5576016A (en) | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
| US5814324A (en) | 1994-02-25 | 1998-09-29 | Takeda Chemical Industries, Ltd. | Injectable composition and a method of producing the same |
| JPH08109165A (ja) * | 1994-08-18 | 1996-04-30 | Chugai Pharmaceut Co Ltd | 一酸化窒素合成酵素阻害作用を有するアミノ酸誘導体 |
| AU3230895A (en) * | 1994-08-18 | 1996-03-14 | Chugai Seiyaku Kabushiki Kaisha | Amino acid derivative having nitrogen monoxide synthetase inhibitor activity |
| DE69923300T2 (de) | 1998-03-09 | 2006-01-05 | Takeda Pharmaceutical Co. Ltd. | Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung |
| CA2400804C (en) | 2000-02-04 | 2009-09-01 | Takeda Chemical Industries, Ltd. | Stable emulsion compositions of cycloalkene derivatives |
-
1999
- 1999-03-08 DE DE69923300T patent/DE69923300T2/de not_active Expired - Lifetime
- 1999-03-08 JP JP05963099A patent/JP3665712B2/ja not_active Expired - Lifetime
- 1999-03-08 CA CA2320467A patent/CA2320467C/en not_active Expired - Fee Related
- 1999-03-08 NZ NZ505874A patent/NZ505874A/en not_active IP Right Cessation
- 1999-03-08 KR KR1020057011882A patent/KR20050071719A/ko not_active Ceased
- 1999-03-08 RU RU2000125568/04A patent/RU2214398C2/ru not_active IP Right Cessation
- 1999-03-08 KR KR1020067001730A patent/KR100779889B1/ko not_active Expired - Fee Related
- 1999-03-08 KR KR10-2000-7009764A patent/KR100492098B1/ko not_active Expired - Lifetime
- 1999-03-08 ID IDW20001736A patent/ID25649A/id unknown
- 1999-03-08 EP EP99907879A patent/EP1063228B1/de not_active Expired - Lifetime
- 1999-03-08 HU HU0101192A patent/HU230061B1/hu not_active IP Right Cessation
- 1999-03-08 US US09/622,392 patent/US6495604B1/en not_active Expired - Lifetime
- 1999-03-08 AU AU27464/99A patent/AU747521B2/en not_active Ceased
- 1999-03-08 KR KR1020057001729A patent/KR100577044B1/ko not_active Expired - Fee Related
- 1999-03-08 WO PCT/JP1999/001103 patent/WO1999046242A1/ja not_active Ceased
- 1999-03-08 CN CNB998029521A patent/CN100432049C/zh not_active Expired - Lifetime
- 1999-03-08 DK DK99907879T patent/DK1063228T5/da active
- 1999-03-08 ES ES99907879T patent/ES2232114T3/es not_active Expired - Lifetime
- 1999-03-08 EP EP05000768A patent/EP1524263A1/de not_active Withdrawn
- 1999-03-08 BR BR9908610-7A patent/BR9908610A/pt not_active IP Right Cessation
- 1999-03-08 AT AT99907879T patent/ATE287393T1/de active
- 1999-03-08 PT PT99907879T patent/PT1063228E/pt unknown
-
2000
- 2000-09-08 NO NO20004485A patent/NO326426B1/no not_active IP Right Cessation
-
2005
- 2005-02-02 JP JP2005026914A patent/JP4342453B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE287393T1 (de) | Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung | |
| DE69726309D1 (de) | Zuckerderivate, geliermittel, geliermittelzubereitungen, verfahren zu ihrer herstellung und gelzubereitungen | |
| ATE420862T1 (de) | 1,2-dihydropyridinverbindungen, verfahren zu deren herstellung und deren verwendung | |
| DE69835877D1 (de) | Trizyklische verbindungen | |
| DE69524251D1 (de) | Neue verbindung, verfahren zu ihrer herstellung und antitumormittel | |
| DE50011034D1 (de) | N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| ATE164582T1 (de) | 1-methylcarbapenemderivate und verfahren zu ihrer herstellung | |
| ATE482930T1 (de) | Substituierte aromatische ringverbindungen, verfahren zu ihrer herstellung und ihre anwendung | |
| ATE240949T1 (de) | Epoxysuccinamid-derivate oder ihre salze | |
| ATE239741T1 (de) | Derivate der phosphonsäure zur inhibierung von carboxypeptidase b | |
| ATE143354T1 (de) | N-alkoxymethylbenzamid-derivate und verfahren zu ihrer herstellung und ihre verwendung zur herstellung von benzamid-derivaten | |
| ATE256108T1 (de) | Verfahren zur herstellung von cholecalciferol- derivaten und zwischenverbindungen | |
| DK0556813T3 (da) | Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler | |
| DE69425970D1 (de) | Benzol-derivate, verwendbar für ischämische erkrankungen | |
| ATE250597T1 (de) | N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung | |
| ATE261441T1 (de) | Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel | |
| DE69818051D1 (de) | N-benzenesulfonyl-l-prolin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung | |
| EP0798304A4 (de) | Medikamente gegen trhombocytopenie | |
| ATE139767T1 (de) | Verfahren zur herstellung 5-pyrazolomerkaptan- derivate und dessen zwischenprodukte | |
| ATE117689T1 (de) | Verfahren zur herstellung von lactamderivaten. | |
| ATE258545T1 (de) | Antioxidantien, verfahren zu ihrer herstellung und ihre verwendungen | |
| TH23733A (th) | สารประกอบคาร์โบไซคลิค |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1063228 Country of ref document: EP |